Found: 30
Select item for more details and to access through your institution.
Effectiveness and safety of secukinumab updosing in patients with moderate to severe plaque psoriasis: data from the PURE registry.
- Published in:
- Archives of Dermatological Research, 2024, v. 316, n. 7, p. 1, doi. 10.1007/s00403-024-03122-w
- By:
- Publication type:
- Article
639 - Efficacy and safety of once-daily roflumilast cream 0.05% in pediatric patients 2 to 5 years of age with mild to moderate atopic dermatitis (INTEGUMENT-PED): a phase 3 randomized controlled trial.
- Published in:
- British Journal of Dermatology, 2024, v. 191, p. 1, doi. 10.1093/bjd/ljae266.020
- By:
- Publication type:
- Article
696 - Sustained improvements over 140 weeks in signs, symptoms, and quality of life with upadacitinib in adolescents and adults with moderate-to-severe atopic dermatitis: integrated results from the phase 3 Measure Up 1 and Measure Up 2 studies.
- Published in:
- British Journal of Dermatology, 2024, v. 191, p. 1, doi. 10.1093/bjd/ljae266.070
- By:
- Publication type:
- Article
644 - Effectiveness and safety of upadacitinib in adolescent and adult patients with atopic dermatitis: an interim analysis of week 20-32 data from a real-world multicenter retrospective review.
- Published in:
- British Journal of Dermatology, 2024, v. 191, p. 1, doi. 10.1093/bjd/ljae266.024
- By:
- Publication type:
- Article
643 - Effectiveness and safety of upadacitinib in adolescent and adult patients with atopic dermatitis: an analysis of short-term (week 8-20) data from a real-world multicenter retrospective review.
- Published in:
- British Journal of Dermatology, 2024, v. 191, p. 1, doi. 10.1093/bjd/ljae266.023
- By:
- Publication type:
- Article
641 - Pooled efficacy, patient-reported outcomes, and safety of roflumilast cream 0.15% from the INTEGUMENT-1 and INTEGUMENT-2 phase 3 trials of adults and children with atopic dermatitis.
- Published in:
- British Journal of Dermatology, 2024, v. 191, p. 1, doi. 10.1093/bjd/ljae266.022
- By:
- Publication type:
- Article
638 - Long-term safety and efficacy of roflumilast cream 0.15% in adults and children aged ≥6 years with mild to moderate atopic dermatitis: a 52-week, phase 3, open-label extension trial.
- Published in:
- British Journal of Dermatology, 2024, v. 191, p. 1, doi. 10.1093/bjd/ljae266.019
- By:
- Publication type:
- Article
647 - Upadacitinib dose alterations in adolescent and adult patients with atopic dermatitis: a real-world multicenter retrospective review.
- Published in:
- British Journal of Dermatology, 2024, v. 191, p. 1, doi. 10.1093/bjd/ljae266.026
- By:
- Publication type:
- Article
645 - Effectiveness and safety of upadacitinib in adolescent and adult patients with atopic dermatitis: an analysis of long-term (week 52) data from a real-world multicenter retrospective review.
- Published in:
- British Journal of Dermatology, 2024, v. 191, p. 1, doi. 10.1093/bjd/ljae266.025
- By:
- Publication type:
- Article
Canadian Expert Consensus on the Use of Halobetasol Propionate/Tazarotene Lotion for Plaque Psoriasis.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 7, p. 1917, doi. 10.1007/s13555-024-01204-1
- By:
- Publication type:
- Article
Upadacitinib Rapidly Improves Patient-Reported Outcomes in Atopic Dermatitis: 16-Week Results from Phase 3 Clinical Trials (Measure Up 1 and 2).
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 5, p. 1127, doi. 10.1007/s13555-024-01157-5
- By:
- Publication type:
- Article
Rapid skin clearance and itch improvement with upadacitinib versus dupilumab in adults with moderate-to-severe atopic dermatitis: results from a phase 3b head-to-head clinical trial (Heads Up).
- Published in:
- British Journal of Dermatology, 2024, v. 190, p. ii30, doi. 10.1093/bjd/ljad498.033
- By:
- Publication type:
- Article
Multicenter Canadian case series of pediatric patients less than 12 years of age with moderate‐to‐severe atopic dermatitis treated with dupilumab.
- Published in:
- Pediatric Dermatology, 2024, v. 41, n. 1, p. 5, doi. 10.1111/pde.15418
- By:
- Publication type:
- Article
Correction to: Use of Systemic Therapies for Treatment of Psoriasis in Patients with a History of Treated Solid Tumours: Inference-Based Guidance from a Multidisciplinary Expert Panel.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
The burden of alopecia areata: A scoping review focusing on quality of life, mental health and work productivity.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2023, v. 37, n. 8, p. 1490, doi. 10.1111/jdv.18926
- By:
- Publication type:
- Article
425 Effect of upadacitinib on SCORAD intensity items: analysis from the Measure Up 1 and Measure Up 2 studies.
- Published in:
- British Journal of Dermatology, 2023, v. 188, p. 1, doi. 10.1093/bjd/ljad162.045
- By:
- Publication type:
- Article
409 Efficacy and safety of upadacitinib in adults and adolescents with moderate-to-severe atopic dermatitis: subgroup analysis of the Measure Up 1, Measure Up 2 and AD Up phase 3 clinical trials at 52 weeks.
- Published in:
- British Journal of Dermatology, 2023, v. 188, p. 1, doi. 10.1093/bjd/ljad162.030
- By:
- Publication type:
- Article
Efficacy and Safety of Upadacitinib Treatment in Adolescents With Moderate-to-Severe Atopic Dermatitis: Analysis of the Measure Up 1, Measure Up 2, and AD Up Randomized Clinical Trials.
- Published in:
- JAMA Dermatology, 2023, v. 159, n. 5, p. 526, doi. 10.1001/jamadermatol.2023.0391
- By:
- Publication type:
- Article
Use of Systemic Therapies for Treatment of Psoriasis in Patients with a History of Treated Solid Tumours: Inference-Based Guidance from a Multidisciplinary Expert Panel.
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 4, p. 867, doi. 10.1007/s13555-023-00905-3
- By:
- Publication type:
- Article
Sustained Effectiveness of Secukinumab Across Different Body Regions in Patients with Moderate-to-Severe Plaque Psoriasis from the PURE Registry.
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 2, p. 535, doi. 10.1007/s13555-022-00870-3
- By:
- Publication type:
- Article
Management of moderate‐to‐severe plaque psoriasis with biologics: A treat‐to‐target position paper.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 10, p. 1, doi. 10.1111/dth.15777
- By:
- Publication type:
- Article
Patch Testing on Dupilumab: Reliable or Not?
- Published in:
- Cutis, 2022, v. 109, n. 3, p. 158, doi. 10.12788/cutis.0471
- By:
- Publication type:
- Article
Unmet Educational Needs and Clinical Practice Gaps in the Management of Generalized Pustular Psoriasis: Global Perspectives from the Front Line.
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 2, p. 381, doi. 10.1007/s13555-021-00661-2
- By:
- Publication type:
- Article
Efficacy and Safety of Upadacitinib vs Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis: A Randomized Clinical Trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Predictors of family impact of juvenile localized scleroderma.
- Published in:
- Pediatric Dermatology, 2021, v. 38, n. 5, p. 1137, doi. 10.1111/pde.14683
- By:
- Publication type:
- Article
Cerebellar Atrophy in Craniofacial Morphea: A Report of 2 Cases with 1-year Neuroimaging Followup.
- Published in:
- 2020
- By:
- Publication type:
- case study
Novel use of Autoinflammatory Diseases Activity Index (AIDAI) captures skin and extracutaneous features to help manage pediatric DITRA: A case report and a proposal for a modified disease activity index in autoinflammatory keratinization disorders.
- Published in:
- Pediatric Dermatology, 2020, v. 37, n. 4, p. 670, doi. 10.1111/pde.14155
- By:
- Publication type:
- Article
Pediatric leukemia cutis: A case series.
- Published in:
- Pediatric Dermatology, 2019, v. 36, n. 5, p. 658, doi. 10.1111/pde.13864
- By:
- Publication type:
- Article
Distinct Cutaneous Manifestations and Cold-Induced Leukocyte Activation Associated With PLCG2 Mutations.
- Published in:
- JAMA Dermatology, 2015, v. 151, n. 6, p. 627, doi. 10.1001/jamadermatol.2014.5641
- By:
- Publication type:
- Article
Dermacase. Pretibial myxedema.
- Published in:
- 2008
- By:
- Publication type:
- journal article